Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Awards
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
    • Women in Healthcare
    • - Luminaries
    • - Top 25 Diversity Leaders
    • - Leaders to Watch
    • - Luminaries
    • - Top 25 Women Leaders
    • - Women to Watch
  • Events
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Custom Media Event: ESG Summit
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Social Determinants of Health Symposium
    • Leadership Symposium
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Diversity Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Strategic Marketing
    • - Virtual Health
  • Listen
    • Podcast - Next Up
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Politics & Policy
October 24, 2020 01:00 AM

Healthcare policy agendas will be driven by congressional, state elections

Rachel Cohrs
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    U.S. Capitol Building
    SYED F. HASHEMI/UNSPLASH

    While the presidential race likely will be top of mind for voters, the November election will also decide legislative agendas in Congress and in the states.

    Down-ballot races will determine who holds the power to decide healthcare policy. Control of the U.S. Senate is up in the air this fall, and the next president, no matter who it is, will have trouble getting substantive policy goals accomplished without a Senate majority.

    The outcome of governors’ races and control of state legislatures will also be crucial as states grapple with dire budget shortfalls, and Medicaid provider pay rates are on the chopping block. State governments also have influence over healthcare coverage and cost containment policy as the prospects of healthcare reform in Congress remain uncertain.

    Much rides on who controls the Senate

    If Democrats gain control of the upper chamber, Senate Minority Leader Chuck Schumer (D-N.Y.) would take on an outsize role shaping health policy. In his home state, Schumer has a fierce hospital lobby to contend with, and he’ll likely weigh its concerns in any debate over healthcare prices or a public insurance option.

    “He would likely make sure the provider rates aren’t pegged to Medicare, and the rates are not draconian,” Capitol Street Managing Director Ipsita Smolinski said.

    It’s unclear where Schumer would fall on prescription drug pricing, specifically supporting a price negotiation mechanism like the one championed by House Speaker Nancy Pelosi (D-Calif.). Senate Democrats voiced dissatisfaction with a bipartisan drug-pricing package assembled this year that didn’t allow Medicare to negotiate prices with drugmakers.

    Schumer would also have to decide whether to accede to progressive Democrats’ demands to eliminate the filibuster and let legislation be passed without minority party support. The filibuster is “hugely important for healthcare, especially for partisan issues like drug-price negotiation or healthcare coverage,” said Matt Kazan, a senior health policy adviser at Avalere Health who was a Senate Finance Committee aide for more than a decade.

    Race for the Senate: 12 Democratic and 23 Republican seats are up for grabs
    Shakeups at two key committees

    Regardless of the power balance in the Senate, two committees with jurisdiction over healthcare will see major leadership shakeups.

    If Republicans retain control, Senate Finance Committee Chair Chuck Grassley (R-Iowa) has reached his term limit for leading the committee, so he will be instead retake the helm of the Senate Judiciary Committee. Sen. Mike Crapo (R-Idaho) is the likeliest senior committee member to take over, though he would have to give up his post as chair of the Senate Banking, Housing and Urban Affairs Committee.

    Crapo indicated some of his healthcare views when he introduced a drug-pricing package compiled by House Republicans as an alternative to the bipartisan compromise co-authored by Grassley. Many conservatives objected to a policy Grassley pushed that would require drugmakers to pay back Medicare if they raise prices faster than inflation. “Almost overnight the default Republican position on some pretty significant Medicare Part D policies changes,” Kazan said.

    Ranking Democrat Ron Wyden (D-Ore.), who would likely assume the chairmanship if Democrats prevail, is engaged on healthcare and has participated in negotiations with Grassley.

    Health committee

    The future of the Senate Health, Education, Labor and Pensions Committee is less clear-cut, as Chair Lamar Alexander (R-Tenn.) is retiring. If the GOP retains control of the Senate, the next committee member in the line of seniority is Sen. Richard Burr (R-N.C.). However, Burr is under investigation for insider trading in the early days of the COVID-19 pandemic, and resigned his chairmanship of the Senate Select Committee on Intelligence.

    North Carolina is a major pharmaceutical and biotechnology hub, and Burr is generally seen as a friend to industry interests. He pushed for repealing the Affordable Care Act’s medical-device tax and for the FDA to speed its approval process.

    Sen. Patty Murray (D-Wash.), the panel’s ranking member, has worked closely with Alexander on healthcare issues, including healthcare contracting and surprise billing.

    The Senate health committee also has jurisdiction over the FDA, which will be critical as the agency navigates approving vaccines and therapeutics to combat COVID-19.

    The House of Representatives is likely to remain under Democratic control, but Appropriations Committee Chair Nita Lowey (D-N.Y.) is retiring. Appropriations health subcommittee Chair Rosa DeLauro (D-Conn.) is one of the top contenders for the powerful perch. DeLauro would likely support party leadership positions on coverage or drug-pricing legislation and prioritize women’s health issues, Smolinski said.

    Likely healthcare leaders in the Senate

    Senate leadership Majority leader Finance chair Health chair
    If GOP retains control Mitch McConnell, Kentucky Mike Crapo,* Idaho Richard Burr,* North Carolina
    If Democrats gain control Chuck Schumer, New York Ron Wyden, Oregon Patty Murray, Washington

    *These senators are next in line based on seniority, but leadership can override the order.
    Source: Modern Healthcare reporting

    State ballot initiatives, races to watch

    There are two major state healthcare ballot initiatives voters will decide this fall: a measure regulating California dialysis clinics and a proposal to give Oklahoma lawmakers more flexibility to fund the state’s Medicaid expansion.

    Proposition 23 in California, which is supported by the influential Service Employees International Union-United Healthcare Workers West union, would require chronic-dialysis clinics to have an on-site physician while patients are treated, report data on infections and get permission from the state before closing clinics.

    Dialysis industry giants DaVita and Fresenius have poured money into defeating the measure—$93 million to proponents’ $6 million, according to state disclosures—claiming it would create arbitrary bureaucratic requirements and cause some clinics to close.

    Proponents say the measure would improve patients’ quality of care. SEIU-UHW spokesman Steve Trossman said the dialysis industry makes massive profits and could afford to comply with the regulations.

    A 2018 SEIU-UHW-backed initiative that would have capped dialysis clinics’ profits failed, and newspaper editorial boards across California urged voters to reject this year’s proposal, calling it an intentional negotiating ploy.

    Oklahoma voters will decide whether to take annual funds from a tobacco company settlement and let lawmakers use it to fund Medicaid programs, including the Medicaid expansion voters approved in June. Republican Gov. Kevin Stitt supports the measure, while the Oklahoma Hospital Association has not taken a position.

    States across the country will be facing a fiscal crunch as tax revenue plummets, and state government elections will determine how states face down their deficits.

    Medicaid provider payments are likely targets, as states have limited options to cut other Medicaid expenditures as a condition of accepting federal aid.

    “The question is how states react to fiscal constraints that they are facing. Will they cut Medicaid? Will they cut elsewhere or create new sources of revenue?” said Heather Howard, a Princeton University lecturer and director of a program that gives states technical assistance on healthcare policy reform.

    ACA backstop

    States are on the forefront of policy innovation, and state legislatures and governors influence how aggressive policymaking could be. States could also step in if the Affordable Care Act is struck down by the Supreme Court this term, Howard said.

    The most significant policy changes will come from states that are able to form so-called trifecta governments, with the governor and both chambers of the state legislature from the same party.

    North Carolina is a battleground for the presidency and the Senate, but the GOP-run state Legislature—that has so far blocked Democratic Gov. Roy Cooper from expanding Medicaid—may also be up for grabs. If Cooper wins reelection and Democrats flip the Legislature, that could pave the way for the state to expand Medicaid.

    Other potential trifectas include Democratic control in Minnesota and Pennsylvania, control by either party in New Hampshire, and GOP control in Alaska, state elections analyst Chaz Nuttycombe wrote for the University of Virginia Center for Politics.

    The open Montana governor’s race will also be pivotal, as Democratic Gov. Steve Bullock reached his term limit and decided to run for the Senate. The state Legislature is currently controlled by Republicans. 

    In the past two years Congress has failed to pass reforms on even such issues as banning surprise billing and lowering prescription drug prices, which both parties generally agree should be addressed. The gridlock could continue no matter who wins the White House, which makes states important fronts of healthcare policy development.

    “There are so many healthcare issues on which states are still innovating to fill that vacuum,” Howard said.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Copy of Copy of mh_20171009_MIPS_WEB_i.jpg
    Insurance lobby calls for greater oversight of private equity deals
    Dr. Ashish Jha: U.S. 'vulnerable' to COVID without new shots
    Dr. Ashish Jha: U.S. 'vulnerable' to COVID without new shots
    Sponsored Content
    Modern Healthcare Alert: Sign up for this breaking news email to be kept in the loop as urgent healthcare business news unfolds.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate/Eligibility
      • 100 Most Influential People
      • 50 Most Influential Clinical Executives
      • Best Places to Work in Healthcare
      • Excellence in Governance
      • Health Care Hall of Fame
      • Healthcare Marketing Impact Awards
      • Top 25 Emerging Leaders
      • Top 25 Innovators
      • Diversity in Healthcare
        • - Luminaries
        • - Top 25 Diversity Leaders
        • - Leaders to Watch
      • Women in Healthcare
        • - Luminaries
        • - Top 25 Women Leaders
        • - Women to Watch
    • Events
      • Conferences
        • Transformation Summit
        • Women Leaders in Healthcare Conference
        • Social Determinants of Health Symposium
        • Leadership Symposium
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Diversity Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Strategic Marketing
        • - Virtual Health
      • Webinars
      • Custom Media Event: ESG Summit
    • Listen
      • Podcast - Next Up
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing